MedTrace Logo

Randomised Controlled Trial of Needle Free Access Devices in Preventing Hemodialysis Blood Stream Infection

NCT01082770 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2010-03-09

No results posted yet for this study

Summary

This study will be a randomised controlled trial examining whether a new type of needle free access device(TEGO) is associated with less episodes of infection of dialysis lines, when compared to the current gold standard.

The investigators hypothesise that there will be less handling of the dialysis line by nursing staff and thus this will lead to lower rates of infection. The investigators will also assess whether these access devices lead to alterations in catheter blood flow rates when compared to the current gold standard.

Conditions

  • Hemodialysis Catheter Blood Stream Infection
  • Central Line Infection
  • Dialysis Line Thrombosis

Interventions

DEVICE

TEGO

A bung that can be attached to the end of dialysis lines that can be directly attached to the dialysis machine with minimal handling

DEVICE

Standard

Patients in this group will have a normal 'bung' placed at the end of their dialysis line, which will need to be removed by nursing staff prior to initiation of dialysis

Sponsors & Collaborators

  • Beaumont Hospital

    lead OTHER

Principal Investigators

  • Peter Conlon, MD · Beaumont Hospital Dublin

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-03-31
Completion
2011-03-31

Countries

  • Ireland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01082770 on ClinicalTrials.gov